Levels and Effects of Nogo-B in Patients With Type 2 Diabetes or Hyperglycemic HUVEC Model.

Key Points

• The aim is to explore the association of Nogo-B levels with vascular complications in type 2 diabetes and its protective role in endothelial cells.
• Assessment of Nogo-B levels in T2DM patients
• In vitro study using hyperglycemic HUVEC model
• Analysis of endothelial cell injury and TGF-β signalling
• Lower Nogo-B levels correlate with increased vascular complications in T2DM patients
• Nogo-B mitigates endothelial cell injury in hyperglycemic conditions
• Alterations in TGF-β signalling are observed with Nogo-B intervention